Aslan Pharmaceuticals Company
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for global markets. The company targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. ASLAN Pharmaceuticals focuses on Asia prevalent tumour types, including biliary tract cancer, gastric cancer and breast cancer. Founded in 2010, ASLAN has rapidly established a strong track record in oncology-focused product development. Since its founding, ASLAN has raised over US$167 million in financing, formed innovative partnerships with pharmaceutical industry leaders and developed four therapeutic medicines that target cancers for which there are few effective treatments.